Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 8Sanofi
02 1Biophore India Pharmaceuticals Pvt Ltd
03 2Dr. Reddy's Laboratories
04 1NanoAlvand
05 1Supriya Lifescience
06 1Naprod Life Sciences
07 1Accord healthcare
08 1Amneal Pharmaceuticals
09 2Arrotex Pharmaceuticals
10 1Aurobindo Pharma Limited
11 2EUGIA PHARMA (AUSTRALIA) PTY LTD
12 1EUGIA PHARMA INC.
13 1GLAND PHARMA LIMITED
14 1Hetero Drugs
15 1JAMP PHARMA
16 1MSN Laboratories
17 1Meitheal Pharmaceuticals
18 1ORIFARM GROUP AS
19 1SEACROSS PHARMACEUTICALS
20 1Teva Pharmaceutical Industries
21 1Zydus Pharmaceuticals
01 2INJ
02 1INJEKTIONSVÄTSKA, LÖSNING
03 3Injection
04 2Injection fluid, resolution
05 1Liquid Injection
06 1Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
07 3SOLUTION
08 9SOLUTION;SUBCUTANEOUS
09 2Solution for injection
10 1Vial
11 6Blank
01 1DISCN
02 1Generic
03 1Lead Market Dossiers- Filed
04 1Originator
05 3Prescription
06 8RX
07 16Blank
01 1Heterix 24
02 2MOZOBIL
03 7Mozobil
04 1Neofor
05 8PLERIXAFOR
06 2PLERIXAFOR EUGIA
07 2PLERIXAFOR INJECTION
08 2Plerixafor ARX
09 1Plerixafor Accord
10 1Plerixafor Seacross
11 4Blank
01 6Australia
02 3Canada
03 4India
04 1Iran
05 1Italy
06 4Norway
07 2South Africa
08 1Sweden
09 9USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : RX
Registration Country : USA
Brand Name : MOZOBIL
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2008-12-15
Application Number : 22311
Regulatory Info : RX
Registration Country : USA
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 205182
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Neofor
Dosage Form : Vial
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Liquid Injection
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : Mozobil
Dosage Form : INJEKTIONSVÄTSKA, LÖSNING
Dosage Strength : 20 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Mozobil
Dosage Form : Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
Dosage Strength : 1 bottle SC 24 mg 20 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Mozobil
Dosage Form : Injection fluid, resolution
Dosage Strength : 20 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : MOZOBIL
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 1.2ML
Approval Date :
Application Number : 2377225
Regulatory Info : Prescription
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Mozobil
Dosage Form : INJ
Dosage Strength : 20mg/ml
Packaging : 1.2X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Mozobil
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Mozobil
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 215334
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 213672
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2024-05-03
Application Number : 206644
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 211901
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 205197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-26
Application Number : 208980
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?